|
Professional Resources for Megace ES Strativa Pharmaceuticals is committed to providing the latest information about Megace ES to healthcare professionals. If your patients don’t have prescription coverage and can’t afford Megace ES, RxHope is a patient assistance program that can help. Patients, physicians, and patient advocates can apply for eligible patients in need. Patients are eligible if they do not have any prescription coverage for Megace ES through any private or government funded prescription programs, including Medicare, Medicaid, and Medicare Part D. For more information about RxHope, go to: www.rxhope.com/megacees. General Resources: Megace ES Prescribing Information
|
Indication
Megace ES (megestrol acetate) is a concentrated suspension indicated for the treatment of anorexia (loss of appetite),
cachexia (severe malnutrition), or an unexplained, significant weight loss in people with a diagnosis of AIDS.1
Megace ES is available by Prescription Only. For full Prescribing Information, click here.
*Adverse events greater than placebo derived from the comprehensive adverse events table (≥5%) in Megace ES and megestrol acetate oral suspension prescribing information.
NanoCrystal® is a registered trade mark of Elan Pharma International Limited, Ireland.